Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years.

Gabriele de Vos, Ramin Nazari, Denisa Ferastraoaru, Purvi Parikh, Rebecca Geliebter, Yikania Pichardo, Andrew Wiznia, David Rosenstreich
Author Information
  1. Gabriele de Vos: Albert Einstein College of Medicine, Bronx, NY 10461, USA. gabriele.de-vos@einstein.yu.edu

Abstract

BACKGROUND: Atopic sensitization to aeroallergens in early life has been found to be a strong risk factor for the development of persisting asthma in young children with recurrent wheeze.
OBJECTIVE: To assess the yield of skin prick test (SPT) compared with allergen specific serum IgE (sIgE) testing at identifying aeroallergen sensitization in atopic children younger than 4 years.
METHODS: Concordance between SPT and allergen-specific sIgE testing for 7 common aeroallergens was analyzed in 40 atopic inner-city children 18 to 48 months of age (mean [SD], 36 [9] months) with recurrent wheezing and family history of asthma and/or eczema.
RESULTS: In 80% of children one or more allergen sensitizations would have been missed if only SPT had been performed, and in 38% of children one or more sensitizations would have been missed if only sIgE testing had been performed. Agreement between the SPT and sIgE test was fair for most allergens (κ = -0.04 to 0.50), as was correlation between sIgE levels and SPT grade (ρ = 0.21 to 0.55). Children with high total sIgE (≥300 kU/L) were more likely to have positive sIgE test results, with negative corresponding SPT results (P = .02).
CONCLUSION: Our study revealed a significant discordance between allergen-specific SPT and sIgE testing results for common aeroallergens, suggesting that both SPT and sIgE testing should be performed when diagnosing allergic sensitization in young children at high risk of asthma.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01028560.

Associated Data

ClinicalTrials.gov | NCT01028560

References

  1. Adv Exp Med Biol. 1996;409:141-6 [PMID: 9095234]
  2. J Pediatr (Rio J). 2006 May-Jun;82(3):204-9 [PMID: 16773176]
  3. Am J Respir Crit Care Med. 2012 Feb 1;185(3):281-5 [PMID: 21960534]
  4. Am J Respir Crit Care Med. 2005 Nov 15;172(10):1253-8 [PMID: 16109980]
  5. Ann Allergy Asthma Immunol. 2011 Aug;107(2):139-44 [PMID: 21802022]
  6. J Mol Biol. 2009 Feb 20;386(2):520-30 [PMID: 19136006]
  7. Allergy. 1998 Sep;53(9):821-32 [PMID: 9788682]
  8. Pediatrics. 2012 Jan;129(1):193-7 [PMID: 22201146]
  9. Lancet. 2008 Sep 20;372(9643):1100-6 [PMID: 18805338]
  10. J Allergy Clin Immunol. 2001 Apr;107(4):744-5 [PMID: 11295672]
  11. J Allergy Clin Immunol. 1976 Jul;58(1 PT. 2):140-8 [PMID: 956554]
  12. J Allergy Clin Immunol. 1997 Sep;100(3):335-40 [PMID: 9314345]
  13. Lancet. 2006 Aug 26;368(9537):763-70 [PMID: 16935687]
  14. Clin Lab. 2011;57(1-2):83-5 [PMID: 21391469]
  15. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1403-6 [PMID: 11029352]
  16. J Allergy Clin Immunol. 2006 Dec;118(6):1249-56 [PMID: 17157654]
  17. Allergy Asthma Proc. 2009 Jul-Aug;30(4):386-96 [PMID: 19772760]
  18. Allergy Asthma Proc. 2011 May-Jun;32(3):198-202 [PMID: 21703099]

Grants

  1. KL2 RR025749/NCRR NIH HHS
  2. TL1 RR025748/NCRR NIH HHS
  3. TL1RR025748/NCRR NIH HHS
  4. KL2RR025749/NCRR NIH HHS
  5. UL1 RR025750/NCRR NIH HHS
  6. UL1RR025750/NCRR NIH HHS

MeSH Term

Adult
Allergens
Antibody Specificity
Child, Preschool
Female
Humans
Hypersensitivity, Immediate
Immunoglobulin E
Infant
Infant, Newborn
Male
Middle Aged
Reproducibility of Results
Skin Tests

Chemicals

Allergens
Immunoglobulin E